Mesaieed's QAR 428 Million Hole Was Made of Ships, Not Molecules
A 65% volume collapse turned a 42% EBITDA margin into -10%, and management declined to take a single question about it
MPHC.QA · Earnings Call · 2026-11-02
The quarter that logistics ate
Mesaieed Petrochemical Holding Company reported a net loss of QAR 428 million for the nine months ended 30 September 2026, against a net profit a year earlier. The cause is stated plainly and it has almost nothing to do with the chemistry Mesaieed actually sells. Revenue fell 65% because sales volumes fell 65%. EBITDA went from a 42% margin to negative 10%. This is not a petrochemical story that happens to be bad; it is a logistics story that has temporarily disabled a petrochemical company.The phrase regional conflict is doing an enormous amount of work in this transcript. It appears once, without naming a geography, an actor, a shipping lane or a resolution path. That vagueness matters more than usual, because the rest of the market has not been vague about it. Middle East conflict was a top-ten global theme in the second quarter of 2026, alongside an Iran conflict cluster that has never fully left the tape. Even in the current quarter, peers are still narrating it — ENM referenced the Iran conflict escalating on 30 October, and 4005.T cited the Middle East situation on 2 November. MPHC, sitting physically inside the region those keywords describe, chose the most generic possible formulation.During the period, the group continued to implement production adjustments in response to the regional conflict. These conditions weighed on MPHC operating performance, resulting in lower production volumes across both the petrochemicals and the chlor-alkali segment.
The fixed-cost vise
What makes the arithmetic brutal is the shape of the cost base. Mesaieed's plants did not stop; they ran at reduced rates, which is the worst operating position in heavy chemicals. Weak sales volume removes the revenue that absorbs the fixed cost, while the fixed cost stays. “Although operating costs decreased in line with lower production and sales volumes, the group continued to incur the fixed costs required to maintain safe, reliable, and efficient operations.” — Sami Mathlouthi, Senior Executive or Operations Head · 2026-11-02 That is why the quarterly deterioration outran the annual one. Group revenue fell 16% quarter-on-quarter while EBITDA fell 80%, and the EBITDA decline compounded into a wider net loss in Q3 than in Q2. The one thing management can point to is the balance sheet: QAR 3.1 billion of cash and bank balances at period end, a liquidity position that management explicitly frames as "substantial financial flexibility to navigate ongoing market and operational uncertainty." Mesaieed is a holding company of joint ventures — QatarEnergy owns 57.9% and supplies most head office functions under a service agreement — so the cash pile is essentially the group's only lever while its JV boards run the plants independently. Set QAR 3.1 billion of cash next to a market capitalisation of roughly $3.05 billion, and a meaningful share of the equity value is currently sitting in the bank rather than in the reactors.Two segments, two entirely different diseases
The petrochemical segment lost QAR 342 million over nine months, against a QAR 477 million profit a year earlier, on volumes down 68% and revenue down 69%. But the quarterly detail is stranger than the annual one. Q3 revenue was almost flat — down only QAR 3 million, or 5% — because an ASP decline was offset by volume recovery. “Revenue remained relatively stable, declining by only QAR 3 million or 5%, as a 10% decrease in average selling prices was largely offset by a 6% increase in sales volume.” — Saoud Ahmed Saifaldeen, Segment Head or Senior Executive - Petrochemical Segment · 2026-11-02 Yet the segment's loss widened from QAR 150 million to QAR 204 million. Volumes up, revenue flat, loss larger — that is margin compression from higher variable costs, and it tells you the underlying spread is deteriorating even as throughput normalises. Chlor-alkali is the opposite problem entirely. It lost QAR 144 million over nine months versus QAR 14 million a year ago, but its Q3 damage came from price, not volume: average selling prices fell 27% quarter-on-quarter after the pricing volatility of Q2, with sales volume broadly stable. The realised-price support that cushioned the first half simply evaporated. Both segments are now posting wider losses, but for incompatible reasons, which makes any single recovery narrative hard to buy.The industrial truth MPHC admits and the market is also saying
Strip out the conflict and there is a second, structural problem. Mesaieed's own description of petrochemical markets matches the rest of the sector rather than anything local:That is the same oversupply-and-feedstock-cost chorus coming from LYB, ORBIA and scores of chemical reporters this earnings season. So the company faces a temporary logistics shock layered on a cyclical price trough — and only the first one is likely to resolve quickly. Note also what has quietly disappeared from the discussion: there is no capital programme, no growth project, no capacity commentary. The chlor-alkali segment and the petrochemical segment are being managed for survival and cash preservation, not expansion. A company that stops talking about growth for a full reporting cycle is telling you something.Petrochemical market conditions remain challenging, with prices under continued pressure from global oversupply, subdued demand across key end markets and ongoing macroeconomic uncertainty.